Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels, invites you to join him for his latest live video webinar:
This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. Anyone who registered for the entire series will receive an email with a link to access the June event.
WHAT YOU WILL LEARN
Dr. Fein will help you and your team stay on top of the current trends and market developments. During the June 25 event, Dr. Fein will focus on the latest developments regarding contract pharmacies in the 340B Drug Pricing Program, including:
- Evolution of the 340B program
- Our 2021 analysis of the 340B contract pharmacy market
- The flow of funds in a 340B contract pharmacy network
- How 340B impacts payers, plan sponsors, and PBMs
- How 340B disrupts manufacturer-PBM rebates
- Current program administration controversies
- The latest manufacturer actions and covered entity responses
- How to make sense of ongoing litigation
- Policy options and actions
- Possible resolutions to the contract pharmacy conflict
- And more!
PLUS: Throughout the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions. The webinar will be 90 minutes to accommodate audience questions.
The 340B Drug Pricing Program remains highly controversial. As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data.
Read on for full details on pricing and registration. You can also watch a brief video invitation.
Read more »
Source: Post feed
